Martin Višňanský, Pharm.D., PhD, MSc., MBA

Last update: 23. 10. 2023

I. BASIC INFORMATION
I.1 Surname Višňanský
I.2 Name Martin
I.3 Titles Pharm.D., PhD, MSc., MBA
I.4 Year of birth 1970
I.5 Name of the workplace University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacy and Social Pharmacy
I.6 Address of the workplace Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position lecturer
I.8 E-mail address martin.visnansky@uvlf.sk
I.9 Hyperlink to the entry of a person in the Register of university staff https://www.portalvs.sk/regzam/detail/21878
I.10 Name of the study field in which a person works at the university pharmacy
I.11 ORCID iD 3
3 Optional item.

II. HIGHER EDUCATION AND FURTHER QUALIFICATION GROWTH
II.a Name of the university or institution II.b Year II.c Study field and programme
II.1 First degree of higher education
II.2 Second degree of higher education Comenius University in Bratislava 1993 clinical pharmacy
II.3 Third degree of higher education Comenius University in Bratislava 2007 corporate management
II.4 Associate professor
II.5 Professor
II.6 Doctor of Science (DrSc.)

III. CURRENT AND PREVIOUS EMPLOYMENT
III.a Occupation-position III.b Institution III.c Duration
assistant - lecturer University of veterinary medicine and pharmacy in Kosice 2013 up to now
Board Member and Director of Strategy and Drug Policy Department General Health Insurance, join-stock company, Bratislava 2008 2010
Chairman of the Board and Managing Director Svet zdravia, join-stock company, Bratislava 2005 2007
Managing Director Boehringer - Ingelheim Pharma, Ltd., Bratislava 2002 2004

IV. DEVELOPMENT OF PEDAGOGICAL, PROFESSIONAL, LANGUAGE, DIGITAL AND OTHER SKILLS
IV.a Activity description, course name, other IV.b Name of the institution IV.c Year
Strategic Management and Financial Management for Pharma Industry SDA Bocconi University, Milan, Italy 2013
Master of Science in Health Technology Assessment and Health Management Università Cattolica del Sacro Cuore, Roma, Italy 2011
Master of Business Administration Katz Graduate School of Business, University of Pittsburgh, PA, USA 2000

V. OVERVIEW OF ACTIVITIES WITHIN THE TEACHING CAREER AT THE UNIVERSITY
V.1. Overview of the profile courses taught in the current academic year according to study programmes
V.1.a Name of the profile course V.1.b Study programme V.1.c Degree V.1.d Field of study

V.2. Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year 4
V.2.a Study programme V.2.b Degree V.2.d Field of study
4 According to Art. 6 para. 4 of the Standards for the Study Programme.

V.3. Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a Name of the field of habilitation procedure and inaugural procedure V.3.b Study field to which it is assigned

V.4. Overview of supervised final theses
V.4.a Bachelor's (first degree) V.4.b Diploma (second degree) V.4.c Dissertation (third degree)
V.4.1 Number of currently supervised theses 0 4 0
V.4.2 Number of defended theses 0 46 0

V.5. Overview of other courses taught in the current academic year according to study programmes
V.5.a Name of the course V.5.b Study programme V.5.c Degree V.5.d Field of study
Economics and management for of pharmacistspharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Rights and ethics for pharmacistspharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy

VI. OVERVIEW OF THE RESEARCH/ARTISTIC/OTHER OUTPUTS
VI.1. Overview of the research/artistic/other outputs and the corresponding citations
VI.1.a Overall VI.1.b Over the last six years
VI.1.1 Number of the research/artictic/other outputs 24 10
VI.1.2 Number of the research/artictic/other outputs registered in the Web of Science or Scopus databases 1 1
VI.1.3 Number of citations corresponding to the research/artictic/other outputs 4 4
VI.1.4 Number of citations registered in the Web of Science or Scopus databases 4 4
VI.1.5 Number of invited lectures at the international, national level 1 1

VI.2. The most significant research/artistic/other outputs 5
1. ÁGH, Tamás - INOTAI, András - SZILBERHORN, László - CULIG, Josip - VIŠŇANSKÝ, Martin - KALÓ, Zoltán - PETROVA, Guenka. A Novel Method for Calculating Medication Adherence to Poly-Pharmacotherapy by Linking General Practice Prescribing Data and Pharmacy Dispensing Records. In: ISPOR : Congress. Value In Health. 2015. ISSN 1098-3015, Vol. 18, č. 7(2015), s. A737.
2. TOMEKOVÁ, Kristína - TOMEK, Dominik - BIELIK, Ján - VIŠŇANSKÝ, Martin. PRM133 – Patient Reported Outcomes with Multiple Sclerosis in Slovakia. In: ISPOR : Congress. Value in Health. 2013. ISSN 1098-3015, Vol. 16, č. 7 (2013), s. A598.
3. LEGIDO-QUIGLEY, Helena - PANTELI, Dimitra - CAR, Josip - MCKEE, Martin - BUSSE, Reinhard - VIŠŇANSKÝ, Martin. Clinical Guidelines for Chronic Conditions in the European Union. Rec. 1. vyd. Geneva : WHO, 2013. ISBN 978-92-890-0021-5, online, 227 s.
4. TOMEK, Dominik - VIŠŇANSKÝ, Martin - MARUŠÁKOVÁ, Elena. HTA Principles Inclusion in New European Union Member States : [Princípy hodnotenia zdravotníckych technológií v nových členských štátoch EÚ] In: ISPOR : Congress. Value In Health. 2012. ISSN 1098-3015, Vol. 15, č. 7(2012), s. A319.
5. TOMEK, Dominik - BIELIK, Ján - VIŠŇANSKÝ, Martin - HELBICH, M. - HRONCOVÁ, Dada. Patient Reported Burden of Asthma Bronchiale in the Slovak Republic : [Výstupy pacientov s diagnózou astma bronchiale na Slovensku] In: ISPOR : Congress. Value In Health. 2011. ISSN 1098-3015, Vol. 14, č. 7(2011), s. A498.
5 Maximum of five most significant outputs, if the RATP form is attached to the application.

VI.3. The most significant research/artistic/other outputs over the last six years 6
1. VIŠŇANSKÝ, Martin - BUTALOVÁ, Anna. Impact of the international reference pricing on access to standard therapy drugs for copd : [Dopad medzinárodného referencovania cien na dostupnosť štandardnej terapie pre liečbu CHOCHP] In: ISPOR Europe 2018-New perspectives for improving 21st century health systems. Value In Health. 2018. ISSN 1098-3015, Vol. 21, suppl. 3 (2018), p. 415-416.
2. VIŠŇANSKÝ, Martin. Is transparency in slovak hta efficient enought? Comparing pharmacoeconomics methodologies used in pricing & reimbursement applications for innovative therapies towards requirements defined by the law : [Je hodnotenie zdravotníckych technológii na Slovensku dostatočne transparentne? Porovnanie farmakoekonomických metód, používaných pri podaní žiadostí o cenu a úhradu pre inovatívne lieky v porovnaní s požiadavkami zákona] In: ISPOR Europe 2018-New perspectives for improving 21st century health systems. Value In Health. 2018. ISSN 1098-3015, Vol. 21, suppl. 3 (2018), p. 318.
3. BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia : [Lieková politika v strednej a východnej Európe - Slovensko] In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49.
(15 - H-index, 0.366 - SJR, Q2 - SJR Best Q)
4. VIŠŇANSKÝ, Martin - KABABIKOVÁ, Diana. Impact of the international reference pricing on access to standard therapy drugs for asthma and COPD : [Dopad medzinárodného referencovania cien na dostupnosť štandardnej terapie astmy a CHOCHP] In: ISPOR : Congress. Value In Health. 2016. ISSN 1098-3015, Vol. 19, č. 7(2016), s. A560.
5. VIŠŇANSKÝ, Martin. International Reference pricing across EU : [Medzinárodné referencovanie cien v EÚ] In: ISPOR : Congress. Value In Health. 2016. ISSN 1098-3015, Vol. 19, č. 7(2016), s. A347.
6 Maximum of five most significant outputs over the last six years, if the RATP form is attached to the application.

VI.4. The most significant citations corresponding to the research/artistic/other outputs 7
1. BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia : [Lieková politika v strednej a východnej Európe - Slovensko] In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49.
(15 - H-index, 0.366 - SJR, Q2 - SJR Best Q)
[1] CRACIUN, Petru - PANA, Marian - LUPULIASA, Dumitru - CRACIUN, Maria-Dorina - TAEREL, Adriana-Elena. PRESCRIPTION DRUG (RX) EVOLUTION IN ROMANIA BETWEEN 2010 AND 2020. In FARMACIA. ISSN 0014-8237, 2021, vol. 69, no. 5, pp. 980-987. Dostupné na: https://doi.org/10.31925/farmacia.2021.5.23.
2. BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia : [Lieková politika v strednej a východnej Európe - Slovensko] In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49.
(15 - H-index, 0.366 - SJR, Q2 - SJR Best Q)
[1] DOLLIVER, Diana S. A supply-based response to a demand-driven problem: a fifteen-year analysis of drug interdiction in Poland. In Crime, Law and Social Change. ISSN 09254994, 2020-01-01, 73, 1, pp.
3. BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia : [Lieková politika v strednej a východnej Európe - Slovensko] In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49.
(15 - H-index, 0.366 - SJR, Q2 - SJR Best Q)
[1] TESAR, Tomas - OBSITNIK, Branislav - KALÓ, Zoltán - KRISTENSEN, Finn Børlum. How changes in reimbursement practices influence the financial sustainability of medicine policy: Lessons learned from Slovakia. In Frontiers in Pharmacology, 2019-01-01, 10, jUN, pp.
4. BUCEK PŠENKOVÁ, Mária - VIŠŇANSKÝ, Martin - MACKOVIČOVÁ, Stanislava - TOMEK, Dominik. The Drug Policy in Central European Countries - Slovakia : [Lieková politika v strednej a východnej Európe - Slovensko] In: Value in Health Regional Issues. 2017. ISSN 2212-1099, Vol. 13(2017), s. 44-49.
(15 - H-index, 0.366 - SJR, Q2 - SJR Best Q)
[1] YFANTOPOULOS, John N. - CHANTZARAS, Athanasios. Drug Policy in Greece. In Value in Health Regional Issues. ISSN 22121099, 2018-09-01, 16, pp. 66-73.
7 Maximum of five most significant citations, if the RATP form is attached to the application.

VI.5. Participation in conducting (leading) the most important research projects or art projects over the last six years 8
8 Maximum of five most significant projects, if the RATP form is attached to the application. In addition to the name and brief characteristics of the project, the type of participation is indicated (in Slovak and in English), if possible, a hyperlink to the project and its outputs and citations are stated as well.

VII. OVERVIEW OF ORGANIZATIONAL EXPERIENCE RELATED TO HIGHER EDUCATION AND RESEARCH/ARTISTIC/OTHER ACTIVITIES 9
VII.a Activity, position VII.b Name of the institution, board VII.c Duration
Chairman CEE Consortium, ISPOR 2019 2021
Chairman Slovak Pharmacoeconomic Society, member of SMS 2017 2022
9 E.g. academic positions, memberships in editorial boards and in scientific and professional societies.

VIII. OVERVIEW OF INTERNATIONAL MOBILITIES AND VISITS ORIENTED ON EDUCATION AND RESEARCH/ARTISTIC/ OTHER ACTIVITIES IN THE GIVEN FIELD OF STUDY
VIII.a Name of the institution VIII.b Address of the institution VIII.c Duration (indicate the duration of stay) VIII.d Mobility scheme, employment contract, other (describe)

IX. OTHER RELEVANT FACTS 10
IX.a If relevant, other activities related to higher education or research/artictic/other activities are mentioned
10 Maximum of 1800 characters, if the RATP form is attached to the application.
Skip to content